Novartis deal on the rocks, page-92

Hi Whytee,
over 70 posts in a just a few days on a stock you dont own.
Bit obvious. You will have a nervous break down if you dont take a rest.

I think your wrong and the company will prosper.
Always difficult to break thru with new Tech.
The Data from ARDS is very valuable to Novartis and Mesoblast.

Perin and SI are moving forward for an approval on the most promising
new treatment seen in CHF in years. multi billion dollar market.
60% in Heart and Stroke. Like my Cardiac surgeon mate said last nite
If the Data is correct its a big advancement and strong chance of approval.
The stroke Data really impressed him.

CLBP still to come.

Your just posting and posting and posting .
All posts looking at worst case.

I dont see it that way and neither do holders.

You keep sprouting but your just boring the pants off me.

Your just a time waster with an agenda.

Aloha,